Free Trial

Absci (ABSI) Competitors

Absci logo
$2.60 -0.17 (-5.96%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ABSI vs. EVH, RDWR, STGW, DGNX, CTOS, ETWO, YEXT, FVRR, TIXT, and EEX

Should you be buying Absci stock or one of its competitors? The main competitors of Absci include Evolent Health (EVH), Radware (RDWR), Stagwell (STGW), Diginex (DGNX), Custom Truck One Source (CTOS), E2open Parent (ETWO), Yext (YEXT), Fiverr International (FVRR), Telus Digital (TIXT), and Emerald (EEX). These companies are all part of the "business services" industry.

Absci vs. Its Competitors

Absci (NASDAQ:ABSI) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Evolent Health has a net margin of -4.54% compared to Absci's net margin of -2,232.13%. Evolent Health's return on equity of 3.64% beat Absci's return on equity.

Company Net Margins Return on Equity Return on Assets
Absci-2,232.13% -53.69% -45.89%
Evolent Health -4.54%3.64%1.44%

Evolent Health has higher revenue and earnings than Absci. Evolent Health is trading at a lower price-to-earnings ratio than Absci, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Absci$4.53M73.35-$103.11M-$0.92-2.83
Evolent Health$2.55B0.53-$61.62M-$1.23-9.46

Absci has a beta of 2.01, meaning that its share price is 101% more volatile than the S&P 500. Comparatively, Evolent Health has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Absci currently has a consensus target price of $8.40, suggesting a potential upside of 222.46%. Evolent Health has a consensus target price of $17.79, suggesting a potential upside of 52.80%. Given Absci's higher probable upside, research analysts clearly believe Absci is more favorable than Evolent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Absci
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Evolent Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
3.00

52.1% of Absci shares are held by institutional investors. 10.5% of Absci shares are held by insiders. Comparatively, 1.6% of Evolent Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Absci and Absci both had 5 articles in the media. Absci's average media sentiment score of 0.58 beat Evolent Health's score of 0.15 indicating that Absci is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Absci
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Evolent Health
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Absci beats Evolent Health on 8 of the 15 factors compared between the two stocks.

Get Absci News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABSI vs. The Competition

MetricAbsciMED IndustryMedical SectorNASDAQ Exchange
Market Cap$332.29M$2.85B$5.45B$8.92B
Dividend YieldN/A2.44%5.22%4.00%
P/E Ratio-2.8320.6327.2720.07
Price / Sales73.35290.56428.46118.22
Price / CashN/A41.7026.2128.59
Price / Book1.677.427.925.58
Net Income-$103.11M-$55.04M$3.17B$248.65M
7 Day Performance1.36%3.70%4.33%7.15%
1 Month Performance-14.03%0.35%2.61%8.13%
1 Year Performance-17.82%4.79%34.78%21.59%

Absci Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABSI
Absci
2.0459 of 5 stars
$2.61
-6.0%
$8.40
+222.5%
-13.1%$332.29M$4.53M-2.83210Gap Up
EVH
Evolent Health
1.565 of 5 stars
$11.31
+1.3%
$17.79
+57.3%
-41.1%$1.31B$2.55B-9.204,500
RDWR
Radware
2.5784 of 5 stars
$29.44
+0.9%
$27.00
-8.3%
+59.0%$1.25B$274.88M109.041,208News Coverage
STGW
Stagwell
2.5228 of 5 stars
$4.50
+0.7%
$9.13
+102.8%
-33.4%$1.20B$2.84B9.9314,607News Coverage
Positive News
DGNX
Diginex
N/A$51.44
+0.3%
N/AN/A$1.16BN/A0.0021
CTOS
Custom Truck One Source
0.604 of 5 stars
$4.96
-1.6%
$5.25
+5.8%
+23.0%$1.14B$1.80B-38.151,800Positive News
ETWO
E2open Parent
1.0788 of 5 stars
$3.24
flat
$2.78
-14.4%
-29.0%$1.11B$607.69M-1.513,873Upcoming Earnings
YEXT
Yext
1.6291 of 5 stars
$8.52
+0.2%
$9.44
+10.8%
+62.6%$1.04B$420.96M-47.331,150
FVRR
Fiverr International
3.8006 of 5 stars
$29.36
+2.5%
$36.00
+22.6%
+24.0%$1.03B$391.48M62.47790
TIXT
Telus Digital
1.5261 of 5 stars
$3.63
+0.8%
$4.05
+11.5%
-35.5%$992.34M$2.66B-7.4178,879
EEX
Emerald
1.9697 of 5 stars
$4.86
-1.6%
$7.90
+62.6%
-4.5%$982.36M$398.80M162.05600

Related Companies and Tools


This page (NASDAQ:ABSI) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners